Deal on Pfizer oral medication for COVID-19 in final stage: PM
Prime Minister Kim Boo-kyum on Dec. 24 chairs a meeting on responding to the COVID-19 pandemic of the Central Disaster and Safety Countermeasures Headquarters at Government Complex-Seoul. (Yonhap News)
By Xu Aiying and Lee Jihae
Prime Minister Kim Boo-kyum says the government is discussing with Pfizer the purchase of oral medications for COVID-19, with contract negotiations in the final stage.
"Pfizer's oral medications for COVID-19 have gained emergency approval for use by the U.S. Food and Drug Administration," he told a meeting on Dec. 24 that he chaired on responding to the pandemic of the Central Disaster and Safety Countermeasures Headquarters at Government Complex-Seoul.
"The government has negotiated the purchase of the medication for more than 300,000 people, far more than the 70,000 it announced earlier," he added. "We will inform the people in depth once the Ministry of Food and Drug Safety issues emergency approval for the medicine's use and the deal is finalized."
"Since the strengthening of quarantine measures began last weekend, the daily number of COVID-19 confirmed cases has fallen to the 7,000 level, but it's too early to conclude that a decline occurred," he said. "We will further raise quarantine measures from this weekend and lead a definite reversal in the (year's) remaining week."
"We will exert all our efforts to secure a sufficient number of hospital beds to accommodate 10,000 confirmed cases per day and boost the turnover rate."
"In particular, if the number of severely ill COVID-19 patients surges, switching some general beds and medical personnel to treatment of the pandemic is inevitable to overcome the crisis, but please understand the difficulties of general treatment in this process," he added. "Unless absolutely necessary, please visit other hospitals or clinics with capacity instead of large hospitals, which are focused on COVID-19 treatment."
On the rise of COVID-19 cases among children, the prime minister said, "The rapid spread of the coronavirus among children ages 11 or younger, who are ineligible for vaccines, is worrying," adding, "The Korea Disease Control and Prevention Agency should closely review in advance whether to vaccinate children after closely examining case studies abroad and scientific evidence."
xuaiy@korea.kr